173 related articles for article (PubMed ID: 37165121)
1. DIPG-like MYB-altered diffuse astrocytoma with durable response to intensive chemotherapy.
Trkova K; Sumerauer D; Krskova L; Vicha A; Koblizek M; Votava T; Priban V; Zapotocky M
Childs Nerv Syst; 2023 Sep; 39(9):2509-2513. PubMed ID: 37165121
[TBL] [Abstract][Full Text] [Related]
2. Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG.
Chiang J; Diaz AK; Makepeace L; Li X; Han Y; Li Y; Klimo P; Boop FA; Baker SJ; Gajjar A; Merchant TE; Ellison DW; Broniscer A; Patay Z; Tinkle CL
Acta Neuropathol Commun; 2020 Apr; 8(1):57. PubMed ID: 32326973
[TBL] [Abstract][Full Text] [Related]
3. Advances and Clinical Trials Update in the Treatment of Diffuse Intrinsic Pontine Gliomas.
Dalle Ore C; Coleman C; Gupta N; Mueller S
Pediatr Neurosurg; 2023; 58(5):259-266. PubMed ID: 36642062
[TBL] [Abstract][Full Text] [Related]
4. A multimodal imaging-based classification for pediatric diffuse intrinsic pontine gliomas.
Pan C; Zhang M; Xiao X; Kong L; Wu Y; Zhao X; Sun T; Zhang P; Geng Y; Zuo P; Wang Y; Li X; Gu G; Li T; Wu Z; Zhang J; Zhang L
Neurosurg Rev; 2023 Jun; 46(1):151. PubMed ID: 37358632
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma.
Noll A; Myers C; Biery MC; Meechan M; Tahiri S; Rajendran A; Berens ME; Paine D; Byron S; Zhang J; Winter C; Pakiam F; Leary SES; Cole BL; Jackson ER; Dun MD; Foster JB; Evans MK; Pattwell SS; Olson JM; Vitanza NA
Neoplasia; 2023 Sep; 43():100921. PubMed ID: 37603953
[TBL] [Abstract][Full Text] [Related]
6. The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease.
Baugh J; Bartels U; Leach J; Jones B; Chaney B; Warren KE; Kirkendall J; Doughman R; Hawkins C; Miles L; Fuller C; Hassall T; Bouffet E; Lane A; Hargrave D; Grill J; Hoffman LM; Jones C; Towbin A; Savage SA; Monje M; Li XN; Ziegler DS; Veldhuijzen van Zanten S; Kramm CM; van Vuurden DG; Fouladi M
J Neurooncol; 2017 Apr; 132(2):323-331. PubMed ID: 28093680
[TBL] [Abstract][Full Text] [Related]
7. Developing H3K27M mutant selective radiosensitization strategies in diffuse intrinsic pontine glioma.
Parsels LA; Wahl DR; Koschmann C; Morgan MA; Zhang Q
Neoplasia; 2023 Mar; 37():100881. PubMed ID: 36724689
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location.
Castel D; Philippe C; Kergrohen T; Sill M; Merlevede J; Barret E; Puget S; Sainte-Rose C; Kramm CM; Jones C; Varlet P; Pfister SM; Grill J; Jones DTW; Debily MA
Acta Neuropathol Commun; 2018 Nov; 6(1):117. PubMed ID: 30396367
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
10. Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas.
Ehteda A; Khan A; Rajakumar G; Vanniasinghe AS; Gopalakrishnan A; Liu J; Tsoli M; Ziegler DS
Mol Cancer Ther; 2023 Dec; 22(12):1413-1421. PubMed ID: 37683275
[TBL] [Abstract][Full Text] [Related]
11. Dimethyl alpha-ketoglutarate inhibits proliferation in diffuse intrinsic pontine glioma by reprogramming epigenetic and transcriptional networks.
Lee K; Yun S; Park J; Lee S; Carcaboso AM; Yi SJ; Kim K
Biochem Biophys Res Commun; 2023 Oct; 677():6-12. PubMed ID: 37523894
[TBL] [Abstract][Full Text] [Related]
12. Diffuse Intrinsic Pontine Glioma: From Diagnosis to Next-Generation Clinical Trials.
Vitanza NA; Monje M
Curr Treat Options Neurol; 2019 Jul; 21(8):37. PubMed ID: 31290035
[TBL] [Abstract][Full Text] [Related]
13. Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials.
Damodharan S; Lara-Velazquez M; Williamsen BC; Helgager J; Dey M
J Pers Med; 2022 May; 12(5):. PubMed ID: 35629262
[TBL] [Abstract][Full Text] [Related]
14. Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.
Carceller F; Fowkes LA; Khabra K; Moreno L; Saran F; Burford A; Mackay A; Jones DT; Hovestadt V; Marshall LV; Vaidya S; Mandeville H; Jerome N; Bridges LR; Laxton R; Al-Sarraj S; Pfister SM; Leach MO; Pearson AD; Jones C; Koh DM; Zacharoulis S
J Neurooncol; 2016 Aug; 129(1):109-21. PubMed ID: 27180091
[TBL] [Abstract][Full Text] [Related]
15. Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications.
Buczkowicz P; Bartels U; Bouffet E; Becher O; Hawkins C
Acta Neuropathol; 2014 Oct; 128(4):573-81. PubMed ID: 25047029
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry.
Erker C; Lane A; Chaney B; Leary S; Minturn JE; Bartels U; Packer RJ; Dorris K; Gottardo NG; Warren KE; Broniscer A; Kieran MW; Zhu X; White P; Dexheimer PJ; Black K; Asher A; DeWire M; Hansford JR; Gururangan S; Nazarian J; Ziegler DS; Sandler E; Bartlett A; Goldman S; Shih CS; Hassall T; Dholaria H; Bandopadhayay P; Samson Y; Monje M; Fisher PG; Dodgshun A; Parkin S; Chintagumpala M; Tsui K; Gass D; Larouche V; Broxson E; Garcia Lombardi M; Wang SS; Ma J; Hawkins C; Hamideh D; Wagner L; Koschmann C; Fuller C; Drissi R; Jones BV; Leach J; Fouladi M
Neuro Oncol; 2022 Jan; 24(1):141-152. PubMed ID: 34114629
[TBL] [Abstract][Full Text] [Related]
17. Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor Recurrence.
Sharma M; Barravecchia I; Teis R; Cruz J; Mumby R; Ziemke EK; Espinoza CE; Krishnamoorthy V; Magnuson B; Ljungman M; Koschmann C; Chandra J; Whitehead CE; Sebolt-Leopold JS; Galban S
Mol Cancer Ther; 2024 Jan; 23(1):24-34. PubMed ID: 37723046
[TBL] [Abstract][Full Text] [Related]
18. Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC).
Fonseca A; Afzal S; Bowes L; Crooks B; Larouche V; Jabado N; Perreault S; Johnston DL; Zelcer S; Fleming A; Scheinemann K; Silva M; Vanan MI; Mpofu C; Wilson B; Eisenstat DD; Lafay-Cousin L; Hukin J; Hawkins C; Bartels U; Bouffet E
J Neurooncol; 2020 Aug; 149(1):45-54. PubMed ID: 32632896
[TBL] [Abstract][Full Text] [Related]
19. Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG).
Gwak HS; Park HJ
Crit Rev Oncol Hematol; 2017 Dec; 120():111-119. PubMed ID: 29198324
[TBL] [Abstract][Full Text] [Related]
20. Cutting Edge Therapeutic Insights Derived from Molecular Biology of Pediatric High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG).
Bailey CP; Figueroa M; Mohiuddin S; Zaky W; Chandra J
Bioengineering (Basel); 2018 Oct; 5(4):. PubMed ID: 30340362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
